These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2210390)

  • 1. Human growth hormone: the Fountain of Youth?
    Walker C
    Geriatrics; 1990 Oct; 45(10):18-9. PubMed ID: 2210390
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
    Ranke MB; Wollmann HA; Savage MO
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():259-66. PubMed ID: 10698590
    [No Abstract]   [Full Text] [Related]  

  • 3. [Growth hormone in the elderly man].
    Riedl M; Kotzmann H; Luger A
    Wien Med Wochenschr; 2001; 151(18-20):426-9. PubMed ID: 11817251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon's Fountain revisited?
    Rosen CJ
    J Cell Biochem; 1994 Nov; 56(3):348-56. PubMed ID: 7876328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Although both rhGh and rhIGF-I have the potential to provide clinical benefit, each also has the potential to produce unwanted side-effects.
    Le Roith D
    Growth Horm IGF Res; 1999 Apr; 9(2):83. PubMed ID: 10373340
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth hormone in adults. An elixir of youth?].
    Rainfray M; Hamon-Vilcot B; Cnockaert X; Pellerin J; Bouillanne O; Durand D; Piette F
    Therapie; 1995; 50(3):271-82. PubMed ID: 7667812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone: beyond therapeutic prescription--a magic fountain of youth?
    Rajasoorya C
    Singapore Med J; 2002 Dec; 43(12):601-4. PubMed ID: 12693761
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is there a place for DHEA, GH and melatonin in the management of age-related androgen deficiency?].
    Estour B; Bossu C; Nicolau A; Rossi D; Tostain J
    Prog Urol; 2004 Nov; 14(5):851-8. PubMed ID: 15747633
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
    Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J
    J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone, somatomedins and men's health.
    Becker AJ; Uckert S; Stief CG; Jonas U
    Aging Male; 2002 Dec; 5(4):258-62. PubMed ID: 12630074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
    Devin JK; Young PP
    Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth hormone and dilated cardiomyopathy].
    Dreifuss P
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1261-3. PubMed ID: 12053286
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Somatopause: the present state-of-art].
    Krysiak R; Kedzia A; Okopień B
    Wiad Lek; 2009; 62(1):52-61. PubMed ID: 19817258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with growth hormone and insulin-like growth factor-I in critical illness.
    Carroll PV
    Best Pract Res Clin Endocrinol Metab; 2001 Dec; 15(4):435-51. PubMed ID: 11800516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor treatment of disorders of skeletal growth.
    Trippel SB; Rosenfeld RG
    Instr Course Lect; 1997; 46():477-82. PubMed ID: 9143990
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone-resistant syndromes: long-term follow-up.
    Chernausek SD
    Endocr Dev; 2009; 14():135-42. PubMed ID: 19293580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient.
    Carroll PV
    Growth Horm IGF Res; 1999 Dec; 9(6):400-13. PubMed ID: 10629160
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin-like growth factor-I, cognition and brain aging.
    van Dam PS; Aleman A
    Eur J Pharmacol; 2004 Apr; 490(1-3):87-95. PubMed ID: 15094076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.